Literature DB >> 16487545

Issues related to botanicals.

Ikhlas A Khan1.   

Abstract

Herbal product studies cannot be considered scientifically valid if the product tested was not authenticated and characterized in order to ensure reproducibility in the manufacturing of the product in question. Many studies refer to the use of standardized material, but in reality they are referring to chemical standardization. While chemical standardization is important, its utility is limited when the starting material is not well characterized botanically. Although the resulting studies are sound with respect to the actual product tested, adequate authentication of the product cannot be compared to other products on the market. Also, a comparison of one study to another cannot be made due to inconsistencies in the identity of the botanical matrix. The tools needed for authentication of the field plant material also depend on the plant and process involved. This could be as straightforward as botanical/morphological identification or as elaborate as genetic or chemical profiling. Authenticated raw material is the basic starting point for the development of a botanical product. However, harvesting, storing, processing and formulating methods may dramatically affect the quality and consistency of the final product by altering the desired marker components or by increasing the possibility of unwanted contaminants. Thus, validated methods to ensure quality control in manufacturing and storage are required tools for optimal efficacy and safety of the products. These controls are also critical for the evaluation of pharmacological, toxicological and clinical studies of the botanical supplements.

Mesh:

Substances:

Year:  2006        PMID: 16487545     DOI: 10.1016/j.lfs.2005.12.019

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  19 in total

Review 1.  Current status and challenges of cytokine pharmacology.

Authors:  Z Zídek; P Anzenbacher; E Kmonícková
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

2.  Combining untargeted and targeted metabolomics approaches for the standardization of polyherbal formulations through UPLC-MS/MS.

Authors:  Saeedur Rahman; Faraz Ul Haq; Arslan Ali; Muhammad Noman Khan; Syed Muhammad Zaki Shah; Achyut Adhikhari; Hesham R El-Seedi; Syed Ghulam Musharraf
Journal:  Metabolomics       Date:  2019-08-22       Impact factor: 4.290

Review 3.  Synergy and antagonism in natural product extracts: when 1 + 1 does not equal 2.

Authors:  Lindsay K Caesar; Nadja B Cech
Journal:  Nat Prod Rep       Date:  2019-06-19       Impact factor: 13.423

4.  A comprehensive platform for quality control of botanical drugs (PhytomicsQC): a case study of Huangqin Tang (HQT) and PHY906.

Authors:  Robert Tilton; Anthony A Paiva; Jing-Qu Guan; Rajendra Marathe; Zaoli Jiang; Winfried van Eyndhoven; Jeffrey Bjoraker; Zachary Prusoff; Hailong Wang; Shwu-Huey Liu; Yung-Chi Cheng
Journal:  Chin Med       Date:  2010-08-20       Impact factor: 5.455

5.  Antiproliferative effects of different plant parts of Panax notoginseng on SW480 human colorectal cancer cells.

Authors:  Chong-Zhi Wang; Jing-Tian Xie; Anna Fishbein; Han H Aung; Hui He; Sangeeta R Mehendale; Tong-Chuan He; Wei Du; Chun-Su Yuan
Journal:  Phytother Res       Date:  2009-01       Impact factor: 5.878

6.  Streamlining plant sample preparation: the use of high-throughput robotics to process echinacea samples for biomarker profiling by MALDI-TOF mass spectrometry.

Authors:  Leasa A Greene; Issa Isaac; Dean E Gray; Sarah A Schwartz
Journal:  J Biomol Tech       Date:  2007-09

7.  Tracking and treating activated T cells.

Authors:  N H Kim; V Nadithe; M Elsayed; O M Merkel
Journal:  J Drug Deliv Sci Technol       Date:  2013-01-01       Impact factor: 3.981

8.  Bromelain treatment reduces CD25 expression on activated CD4+ T cells in vitro.

Authors:  Eric R Secor; Anurag Singh; Linda A Guernsey; Jeff T McNamara; Lijun Zhan; Nilanjana Maulik; Roger S Thrall
Journal:  Int Immunopharmacol       Date:  2009-01-20       Impact factor: 4.932

9.  Science across borders: 5th annual natural health product research conference-march 26-29, 2008, toronto, Canada.

Authors:  Muhammad Nabeel Ghayur
Journal:  Evid Based Complement Alternat Med       Date:  2008-09-04       Impact factor: 2.629

10.  LC-MS/MS Identification of a Bromelain Peptide Biomarker from Ananas comosus Merr.

Authors:  Eric R Secor; Steven M Szczepanek; Anurag Singh; Linda Guernsey; Prabitha Natarajan; Karim Rezaul; David K Han; Roger S Thrall; Lawrence K Silbart
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-02       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.